Scleroderma
Scleroderma, or systemic sclerosis, encompasses a group of rare diseases characterized by the hardening and tightening of the skin, potentially affecting blood vessels, internal organs, and the digestive tract. Categorized as “limited” or “diffuse,” referring to the degree of skin involvement, it may also manifest as localized scleroderma, known as morphea, impacting only the skin. Symptoms vary, including skin hardening, Raynaud’s phenomenon, digestive issues, and heart and lung problems. Scleroderma has no cure, but treatments aim to alleviate symptoms, slow progression, and enhance quality of life. It predominantly occurs in women over 40, and genetics, immune system problems, and environmental triggers contribute to its development. Complications involve fingertips, lungs, kidneys, heart, teeth, digestive system, and joints, ranging from mild to severe. Timely medical attention is crucial for proper management.